AZN - AstraZeneca reports positive liver cancer study results for Imfinzi
2024-01-19 16:55:40 ET
More on AstraZeneca
- Why AstraZeneca's Gracell Biotechnologies Acquisition Is A Win-Win
- AstraZeneca: A $1.1B Shot In The Arm From Icosavax Acquisition
- AstraZeneca Is Feeling The Weight Of The Market In 2023
- AstraZeneca PNH drug gets first regulatory approval in Japan
- Icosavax ticks lower as HSR filing for AstraZeneca deal withdrawn, refiled
For further details see:
AstraZeneca reports positive liver cancer study results for Imfinzi